4P-Pharma working with VC and investor_final-03

4P-Pharma working with VC and investors_final-02


We take advantage of the consolidated experience of our founders and a long track of successful maturation programs that has been achieved in the past in multiple fields (inflammation, drug delivery, CNS, drug abuse, generic repositioning). This experience tells us that only 10-20% of the technologies that have been developed in a single laboratory (either academic or private) can actually work if tested in an independent environment. We ensure an unbiased validation of these technologies in our laboratories, via well-accepted and routinely-performed preclinical models, demonstrating technical merit via the 4 P’s of preclinical development: proof of mechanism, proof of principle, proof of concept, proof of relevancy. We develop in-house only technologies that strictly pass our go-no go criteria and validation stages.